It should be noted that in the underlying trial and also in general there is a relevant association of BRAF-mutation with right-sided primary tumor localization affecting our overlapping findings (Kohne et al. 2019; Roth et al. 2010; Tran et al. 2011). Here, BRAF is linked to neoplasm.